| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA2 WAPL MYO6 LONP2 MCM6 CHD3 RUVBL2 KIF20B CHD5 MACF1 MORC3 KIF18B DNAH9 DDX39B XRCC6 DNAH11 KIF1C HELLS | 3.17e-06 | 614 | 164 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA2 LONP2 MCM6 CHD3 RUVBL2 KIF20B CHD5 MACF1 MORC3 KIF18B DNAH9 DDX39B XRCC6 DNAH11 KIF1C | 3.76e-06 | 441 | 164 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 8.68e-05 | 127 | 164 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHAC2 PCDHA13 PCDHA12 NBPF26 PCDHA3 ADGRV1 PLA2G4D FSCB TGM3 CELSR1 CELSR3 GUCA1B PCDHGB4 MACF1 PLCB3 CDH11 CDH18 | 1.50e-04 | 749 | 164 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA2 RASA1 LONP2 MCM6 CHD3 RUVBL2 KIF20B MTIF2 CHD5 MACF1 MORC3 KIF18B DNAH9 DDX39B XRCC6 DNAH11 KIF1C | 2.24e-04 | 775 | 164 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.77e-04 | 70 | 164 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | helicase activity | 3.35e-04 | 158 | 164 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 3.40e-04 | 17 | 164 | 3 | GO:0008574 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.32e-04 | 118 | 164 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA2 RASA1 LONP2 MCM6 CHD3 RUVBL2 KIF20B MTIF2 CHD5 MACF1 MORC3 KIF18B DNAH9 DDX39B XRCC6 DNAH11 KIF1C | 5.56e-04 | 839 | 164 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA2 RASA1 LONP2 MCM6 CHD3 RUVBL2 KIF20B MTIF2 CHD5 MACF1 MORC3 KIF18B DNAH9 DDX39B XRCC6 DNAH11 KIF1C | 5.64e-04 | 840 | 164 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA2 RASA1 LONP2 MCM6 CHD3 RUVBL2 KIF20B MTIF2 CHD5 MACF1 MORC3 KIF18B DNAH9 DDX39B XRCC6 DNAH11 KIF1C | 5.64e-04 | 840 | 164 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 6.60e-04 | 5 | 164 | 2 | GO:0140444 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHAC2 PCDHA13 PCDHA12 PCDHA3 CELSR1 CELSR3 PCDHGB4 CDH11 CDH18 | 1.43e-05 | 187 | 158 | 9 | GO:0007156 |
| MousePheno | fused inner hair cell stereocilia | 4.11e-06 | 12 | 137 | 4 | MP:0004533 | |
| MousePheno | organ of Corti degeneration | 1.25e-05 | 53 | 137 | 6 | MP:0000043 | |
| MousePheno | cochlear degeneration | 3.11e-05 | 62 | 137 | 6 | MP:0000032 | |
| MousePheno | fused outer hair cell stereocilia | 4.97e-05 | 8 | 137 | 3 | MP:0004528 | |
| MousePheno | abnormal outer hair cell stereociliary bundle morphology | 5.28e-05 | 68 | 137 | 6 | MP:0004527 | |
| MousePheno | abnormal inner hair cell stereociliary bundle morphology | 7.49e-05 | 45 | 137 | 5 | MP:0004532 | |
| MousePheno | cochlear hair cell degeneration | 8.10e-05 | 106 | 137 | 7 | MP:0004362 | |
| MousePheno | impaired swimming | 1.32e-04 | 80 | 137 | 6 | MP:0001522 | |
| Domain | DUF1220 | 1.92e-08 | 11 | 160 | 5 | PF06758 | |
| Domain | NBPF_dom | 1.92e-08 | 11 | 160 | 5 | IPR010630 | |
| Domain | NBPF | 1.92e-08 | 11 | 160 | 5 | PS51316 | |
| Domain | Cadherin_CS | PCDHAC2 PCDHA13 PCDHA12 PCDHA3 CELSR1 CELSR3 PCDHGB4 CDH11 CDH18 | 4.07e-07 | 109 | 160 | 9 | IPR020894 |
| Domain | CADHERIN_1 | PCDHAC2 PCDHA13 PCDHA12 PCDHA3 CELSR1 CELSR3 PCDHGB4 CDH11 CDH18 | 5.54e-07 | 113 | 160 | 9 | PS00232 |
| Domain | Cadherin | PCDHAC2 PCDHA13 PCDHA12 PCDHA3 CELSR1 CELSR3 PCDHGB4 CDH11 CDH18 | 5.54e-07 | 113 | 160 | 9 | PF00028 |
| Domain | CADHERIN_2 | PCDHAC2 PCDHA13 PCDHA12 PCDHA3 CELSR1 CELSR3 PCDHGB4 CDH11 CDH18 | 5.97e-07 | 114 | 160 | 9 | PS50268 |
| Domain | - | PCDHAC2 PCDHA13 PCDHA12 PCDHA3 CELSR1 CELSR3 PCDHGB4 CDH11 CDH18 | 5.97e-07 | 114 | 160 | 9 | 2.60.40.60 |
| Domain | DUF1220 | 6.32e-07 | 9 | 160 | 4 | SM01148 | |
| Domain | CA | PCDHAC2 PCDHA13 PCDHA12 PCDHA3 CELSR1 CELSR3 PCDHGB4 CDH11 CDH18 | 6.43e-07 | 115 | 160 | 9 | SM00112 |
| Domain | Cadherin-like | PCDHAC2 PCDHA13 PCDHA12 PCDHA3 CELSR1 CELSR3 PCDHGB4 CDH11 CDH18 | 6.92e-07 | 116 | 160 | 9 | IPR015919 |
| Domain | Cadherin | PCDHAC2 PCDHA13 PCDHA12 PCDHA3 CELSR1 CELSR3 PCDHGB4 CDH11 CDH18 | 7.99e-07 | 118 | 160 | 9 | IPR002126 |
| Domain | Spectrin_repeat | 4.36e-06 | 29 | 160 | 5 | IPR002017 | |
| Domain | SPEC | 7.24e-06 | 32 | 160 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 7.24e-06 | 32 | 160 | 5 | IPR018159 | |
| Domain | Cadherin_tail | 1.51e-05 | 37 | 160 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 1.51e-05 | 37 | 160 | 5 | IPR031904 | |
| Domain | Plectin | 2.11e-05 | 7 | 160 | 3 | PF00681 | |
| Domain | Plectin_repeat | 2.11e-05 | 7 | 160 | 3 | IPR001101 | |
| Domain | PLEC | 2.11e-05 | 7 | 160 | 3 | SM00250 | |
| Domain | Spectrin | 4.05e-05 | 23 | 160 | 4 | PF00435 | |
| Domain | UCR_hinge | 7.29e-05 | 2 | 160 | 2 | PF02320 | |
| Domain | Cyt_b-c1_6 | 7.29e-05 | 2 | 160 | 2 | IPR003422 | |
| Domain | AP1_complex_gsu | 7.29e-05 | 2 | 160 | 2 | IPR017107 | |
| Domain | Ubol_cytC_Rdtase_hinge_dom | 7.29e-05 | 2 | 160 | 2 | IPR023184 | |
| Domain | - | 7.29e-05 | 2 | 160 | 2 | 1.10.287.20 | |
| Domain | P-loop_NTPase | ABCA2 GTPBP6 MYO6 LONP2 DAPK1 MCM6 CHD3 PAPSS1 RUVBL2 KIF20B SBNO2 MTIF2 CHD5 KIF18B DNAH9 DDX39B DNAH11 KIF1C HELLS | 1.22e-04 | 848 | 160 | 19 | IPR027417 |
| Domain | ARM-type_fold | MON2 DOCK3 WAPL INTS1 NOC3L CUL7 ARFGEF3 AP1G1 AP1G2 ULK4 TBCD | 1.68e-04 | 339 | 160 | 11 | IPR016024 |
| Domain | CHD_N | 2.18e-04 | 3 | 160 | 2 | IPR012958 | |
| Domain | CHD_C2 | 2.18e-04 | 3 | 160 | 2 | IPR012957 | |
| Domain | CHDCT2 | 2.18e-04 | 3 | 160 | 2 | PF08074 | |
| Domain | CHDNT | 2.18e-04 | 3 | 160 | 2 | PF08073 | |
| Domain | DUF1086 | 2.18e-04 | 3 | 160 | 2 | IPR009462 | |
| Domain | DUF1087 | 2.18e-04 | 3 | 160 | 2 | IPR009463 | |
| Domain | DUF1087 | 2.18e-04 | 3 | 160 | 2 | PF06465 | |
| Domain | DUF1086 | 2.18e-04 | 3 | 160 | 2 | PF06461 | |
| Domain | DUF1087 | 2.18e-04 | 3 | 160 | 2 | SM01147 | |
| Domain | DUF1086 | 2.18e-04 | 3 | 160 | 2 | SM01146 | |
| Domain | Cadherin_2 | 2.37e-04 | 65 | 160 | 5 | PF08266 | |
| Domain | Cadherin_N | 2.37e-04 | 65 | 160 | 5 | IPR013164 | |
| Domain | CH | 2.37e-04 | 65 | 160 | 5 | SM00033 | |
| Domain | CH | 3.35e-04 | 70 | 160 | 5 | PF00307 | |
| Domain | - | 3.58e-04 | 71 | 160 | 5 | 1.10.418.10 | |
| Domain | CH | 4.07e-04 | 73 | 160 | 5 | PS50021 | |
| Domain | KASH | 4.33e-04 | 4 | 160 | 2 | IPR012315 | |
| Domain | KASH | 4.33e-04 | 4 | 160 | 2 | PS51049 | |
| Domain | DCB_dom | 4.33e-04 | 4 | 160 | 2 | IPR032629 | |
| Domain | KASH | 4.33e-04 | 4 | 160 | 2 | SM01249 | |
| Domain | Sec7_C | 4.33e-04 | 4 | 160 | 2 | IPR015403 | |
| Domain | DUF1981 | 4.33e-04 | 4 | 160 | 2 | PF09324 | |
| Domain | KASH | 4.33e-04 | 4 | 160 | 2 | PF10541 | |
| Domain | DCB | 4.33e-04 | 4 | 160 | 2 | PF16213 | |
| Domain | CH-domain | 4.61e-04 | 75 | 160 | 5 | IPR001715 | |
| Domain | GAE | 7.17e-04 | 5 | 160 | 2 | PS50180 | |
| Domain | ACTININ_2 | 9.63e-04 | 23 | 160 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.63e-04 | 23 | 160 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.63e-04 | 23 | 160 | 3 | IPR001589 | |
| Domain | - | 1.07e-03 | 6 | 160 | 2 | 3.90.1290.10 | |
| Domain | - | 1.07e-03 | 6 | 160 | 2 | 2.60.40.1230 | |
| Domain | GAR | 1.07e-03 | 6 | 160 | 2 | PS51460 | |
| Domain | GAS2 | 1.07e-03 | 6 | 160 | 2 | PF02187 | |
| Domain | Clathrin_g-adaptin_app | 1.07e-03 | 6 | 160 | 2 | IPR008153 | |
| Domain | - | 1.07e-03 | 6 | 160 | 2 | 3.30.920.20 | |
| Domain | Liprin | 1.07e-03 | 6 | 160 | 2 | IPR029515 | |
| Domain | GAS_dom | 1.07e-03 | 6 | 160 | 2 | IPR003108 | |
| Domain | GAS2 | 1.07e-03 | 6 | 160 | 2 | SM00243 | |
| Domain | SCAN | 1.35e-03 | 56 | 160 | 4 | SM00431 | |
| Domain | SCAN_BOX | 1.54e-03 | 58 | 160 | 4 | PS50804 | |
| Domain | SCAN | 1.54e-03 | 58 | 160 | 4 | PF02023 | |
| Domain | SCAN_dom | 1.54e-03 | 58 | 160 | 4 | IPR003309 | |
| Domain | Retrov_capsid_C | 1.64e-03 | 59 | 160 | 4 | IPR008916 | |
| Domain | FHA | 1.73e-03 | 28 | 160 | 3 | SM00240 | |
| Domain | Cullin_neddylation_domain | 1.97e-03 | 8 | 160 | 2 | IPR019559 | |
| Domain | DHC_N1 | 1.97e-03 | 8 | 160 | 2 | PF08385 | |
| Domain | Calx_beta | 1.97e-03 | 8 | 160 | 2 | SM00237 | |
| Domain | Cullin_Nedd8 | 1.97e-03 | 8 | 160 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 1.97e-03 | 8 | 160 | 2 | SM00884 | |
| Domain | Dynein_heavy_dom-1 | 1.97e-03 | 8 | 160 | 2 | IPR013594 | |
| Domain | FHA_DOMAIN | 2.33e-03 | 31 | 160 | 3 | PS50006 | |
| Domain | FHA | 2.33e-03 | 31 | 160 | 3 | PF00498 | |
| Domain | Calx_beta | 2.52e-03 | 9 | 160 | 2 | IPR003644 | |
| Domain | Alpha_adaptinC2 | 2.52e-03 | 9 | 160 | 2 | PF02883 | |
| Domain | Cullin_homology | 2.52e-03 | 9 | 160 | 2 | IPR016158 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 2.52e-03 | 9 | 160 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 2.52e-03 | 9 | 160 | 2 | SM00809 | |
| Domain | Calx-beta | 2.52e-03 | 9 | 160 | 2 | PF03160 | |
| Domain | SNF2_N | 2.55e-03 | 32 | 160 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.55e-03 | 32 | 160 | 3 | PF00176 | |
| Domain | GPS | 3.04e-03 | 34 | 160 | 3 | SM00303 | |
| Domain | Cullin | 3.14e-03 | 10 | 160 | 2 | PF00888 | |
| Domain | CULLIN_2 | 3.14e-03 | 10 | 160 | 2 | PS50069 | |
| Domain | Cullin_N | 3.14e-03 | 10 | 160 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 3.14e-03 | 10 | 160 | 2 | PS01256 | |
| Domain | GPS | 3.30e-03 | 35 | 160 | 3 | PF01825 | |
| Domain | - | 3.58e-03 | 36 | 160 | 3 | 2.60.200.20 | |
| Domain | FHA_dom | 3.58e-03 | 36 | 160 | 3 | IPR000253 | |
| Domain | GPS | 3.58e-03 | 36 | 160 | 3 | PS50221 | |
| Domain | PH_dom-like | RASA1 SPTBN2 RDX EPB41L4A MTMR3 SPRED1 PLCB3 FGD5 FRMPD3 FAM43A | 3.76e-03 | 426 | 160 | 10 | IPR011993 |
| Domain | GAIN_dom_N | 3.81e-03 | 11 | 160 | 2 | IPR032471 | |
| Domain | GAIN | 3.81e-03 | 11 | 160 | 2 | PF16489 | |
| Pubmed | NBPF8 NBPF12 NBPF11 NBPF20 NBPF1 NBPF19 NBPF15 NBPF9 NBPF10 NBPF14 | 2.26e-18 | 21 | 172 | 10 | 16079250 | |
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 2.77e-12 | 10 | 172 | 6 | 22973535 | |
| Pubmed | NBPF8 FRAS1 SETMAR ABCA2 NBPF12 RRP1B MYO6 NBPF11 RUVBL2 NBPF1 ZNF462 NBPF15 CELSR3 ASXL3 NBPF9 MDC1 NBPF10 NBPF14 XRCC6 | 1.26e-11 | 513 | 172 | 19 | 25798074 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | DOCK3 CUL3 HIVEP1 RRP1B CYP46A1 CLASRP ARFGEF3 CELSR3 ASXL3 MDC1 CHEK2 MACF1 PRPF38A DNAH9 DDX39B FAM43A | 4.11e-11 | 361 | 172 | 16 | 26167880 |
| Pubmed | CUL3 DIP2B FRAS1 PDE3B WAPL LONP2 UTP14A RDX CHD3 WLS RUVBL2 SBNO2 LLGL1 AP1G1 MTIF2 SHCBP1 PLCB3 IQGAP3 USP33 HELLS | 9.63e-11 | 650 | 172 | 20 | 38777146 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 DOCK3 FRAS1 ABCA2 EPPK1 GTPBP6 INTS1 ITGA3 SBNO2 NBPF1 NCOR1 CELSR1 SYNE3 EIF4ENIF1 CELSR3 CHD5 SNX8 MTMR3 USP7 ANKRD11 AP1G2 ULK4 SH3BP5L IQGAP3 TBCD | 2.54e-10 | 1105 | 172 | 25 | 35748872 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SDE2 WAPL HIVEP1 RRP1B ZSCAN26 INTS1 CHD3 UBR7 KIF20B ZNF462 CHD5 MDC1 USP7 MORC3 KIF18B XRCC6 HELLS | 1.09e-08 | 608 | 172 | 17 | 36089195 |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | NBPF8 NBPF12 CHD3 NBPF11 PPL NBPF1 NBPF9 SYNE2 NBPF10 NBPF14 | 1.44e-08 | 170 | 172 | 10 | 23314748 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UTP6 WAPL GNE MYO6 PMPCB UTP14A NOC3L MCM6 RUVBL2 KIF20B TGM3 LLGL1 AP1G1 SHCBP1 MDC1 USP7 AP1G2 MACF1 PRPF38A KIF18B QARS1 MVP NUP160 DDX39B XRCC6 | 1.49e-08 | 1353 | 172 | 25 | 29467282 |
| Pubmed | UTP6 EPPK1 RRP1B SPTBN2 UTP14A INTS1 NOC3L MCM6 CUL7 TGM3 MDC1 SYNE2 USP7 MACF1 MVP NUP160 XRCC6 | 3.08e-08 | 653 | 172 | 17 | 22586326 | |
| Pubmed | RPGRIP1 GTPBP6 PDGFA PMPCB PPFIA4 PPFIA1 DZIP1L SPTBN2 UTP14A ZSCAN26 BAG1 NOC3L RDX CHD3 PLA2G4D PPL NCOR1 CHD5 SYNE2 PCDHGB4 MACF1 UQCRH DDX39B UQCRHL XRCC6 | 5.13e-08 | 1442 | 172 | 25 | 35575683 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CUL3 UTP6 EPPK1 RRP1B MYO6 PMPCB SPTBN2 UTP14A NOC3L RUVBL2 KIF20B MRPS22 PPL TGM3 CHD5 MDC1 USP7 QARS1 MVP IQGAP3 NUP160 DDX39B XRCC6 | 7.13e-08 | 1257 | 172 | 23 | 36526897 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 7.19e-08 | 72 | 172 | 7 | 10380929 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | WAPL EPPK1 RRP1B INTS1 NOC3L MCM6 CHD3 RUVBL2 MDC1 USP7 KIF18B QARS1 XRCC6 | 9.54e-08 | 394 | 172 | 13 | 27248496 |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 1.50e-07 | 80 | 172 | 7 | 10716726 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | UTP6 FRAS1 LONP2 UTP14A NOC3L MCM6 CHD3 KIF20B MRPS22 AP1G1 SHCBP1 MRPS14 KIF18B | 1.51e-07 | 410 | 172 | 13 | 26949251 |
| Pubmed | UTP14A INTS1 CHD3 CUL7 MRPS22 ZNF462 NCOR1 SHCBP1 USP7 MACF1 IQGAP3 | 1.82e-07 | 282 | 172 | 11 | 23667531 | |
| Pubmed | CUL3 WAPL EPPK1 NUP210L RUVBL2 FSCB AP1G1 MDC1 SYNE2 USP7 ULK4 ZSCAN2 FGD5 TAF12 ZRANB1 NUP160 XRCC6 | 2.38e-07 | 754 | 172 | 17 | 35906200 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MON2 CUL3 PRPSAP2 GNE PPFIA1 BAG1 GINS4 RDX DDI2 MCM6 PAPSS1 RUVBL2 UBR7 AP1G1 USP7 RPUSD2 MACF1 PLCB3 QARS1 MVP NUP160 DDX39B XRCC6 TBCD | 2.42e-07 | 1455 | 172 | 24 | 22863883 |
| Pubmed | 2.96e-07 | 130 | 172 | 8 | 12421765 | ||
| Pubmed | DOCK3 SETMAR ABCA2 WAPL GTPBP6 MYO6 SPTBN2 PEG3 RDX APP CELSR3 MTIF2 MTMR3 USP7 MACF1 SPRED1 MORC3 TAF12 QARS1 MVP XRCC6 USP33 | 4.34e-07 | 1285 | 172 | 22 | 35914814 | |
| Pubmed | 7.56e-07 | 15 | 172 | 4 | 15640798 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | UTP6 EPPK1 RRP1B SPTBN2 UTP14A INTS1 MCM6 CHD3 CUL7 APP RUVBL2 MDC1 SYNE2 MACF1 QARS1 NUP160 DDX39B XRCC6 HELLS | 8.68e-07 | 1024 | 172 | 19 | 24711643 |
| Pubmed | 1.18e-06 | 156 | 172 | 8 | 37108203 | ||
| Pubmed | 1.31e-06 | 17 | 172 | 4 | 29911975 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF449 DIP2B PDE3B GTPBP6 RASA1 MYO6 CHD3 ADGRV1 APP ZHX2 SSPOP SBNO2 NBPF1 OPRL1 ZNF462 ARFGEF3 PARP10 SYNJ2 ANKRD11 ZFHX2 MACF1 ZRANB1 TBCD | 1.36e-06 | 1489 | 172 | 23 | 28611215 |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 1.67e-06 | 18 | 172 | 4 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 1.67e-06 | 18 | 172 | 4 | 10662547 | |
| Pubmed | HIVEP1 PPFIA4 PPFIA1 PEG3 ZHX2 SSPOP UBR7 PPL CLASRP NCOR1 KIAA1549L EIF4ENIF1 USP7 AP1G2 | 2.26e-06 | 608 | 172 | 14 | 16713569 | |
| Pubmed | 2.35e-06 | 6 | 172 | 3 | 24285636 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | UTP6 WAPL HIVEP1 RRP1B MYO6 PMPCB UTP14A NOC3L RDX MCM6 RUVBL2 TGM3 AP1G1 MDC1 USP7 FGD5 QARS1 IQGAP3 NUP160 DDX39B XRCC6 HELLS | 2.38e-06 | 1425 | 172 | 22 | 30948266 |
| Pubmed | 2.38e-06 | 77 | 172 | 6 | 10835267 | ||
| Pubmed | HIVEP1 RRP1B MYO6 UTP14A NOC3L CHD3 CUL7 ZHX2 RUVBL2 MRPS22 ZNF462 NCOR1 EIF4ENIF1 CHD5 MDC1 SYNE2 MRPS14 USP7 TAF12 QARS1 XRCC6 HELLS | 2.49e-06 | 1429 | 172 | 22 | 35140242 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MON2 CUL3 RPGRIP1 IFT140 RRP1B LONP2 MCM6 NUF2 HIF1AN CLASRP PHKG2 EIF4ENIF1 PTPRQ PRPF38A MORC3 KIF18B QARS1 IQGAP3 NUP160 TBCD KIF1C | 2.61e-06 | 1321 | 172 | 21 | 27173435 |
| Pubmed | CUL3 PRPSAP2 ABCA2 MYO6 PMPCB PEG3 UTP14A GINS4 MCM6 CHD3 RUVBL2 MRPS22 GLDC SHCBP1 MRPS14 MTMR3 USP7 QARS1 NUP160 DDX39B XRCC6 | 3.08e-06 | 1335 | 172 | 21 | 29229926 | |
| Pubmed | UTP6 HIVEP1 MYO6 TNC ITGA3 NCOR1 NBPF15 ASXL3 SYNE2 MRPS14 FGD5 UQCRH DNAH11 HELLS | 3.93e-06 | 638 | 172 | 14 | 31182584 | |
| Pubmed | FRAS1 PDE3B RRP1B MYO6 PMPCB PPFIA1 SPTBN2 UTP14A BAG1 NOC3L APP MRPS22 SYNE3 LLGL1 MTIF2 SYNE2 MRPS14 ANKRD11 MACF1 XRCC6 USP33 HELLS | 4.69e-06 | 1487 | 172 | 22 | 33957083 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | UTP6 FAM234B SDE2 PDE3B WAPL MYO6 NOC3L MCM6 APP WLS ARFGEF3 AP1G1 UQCRH QARS1 IQGAP3 TBCD HELLS | 4.88e-06 | 942 | 172 | 17 | 31073040 |
| Pubmed | GTPBP6 RRP1B LONP2 PPFIA1 UTP14A INTS1 NOC3L NBPF26 APP ZHX2 KIF20B MRPS22 CELSR1 EIF4ENIF1 AP1G1 MDC1 MRPS14 USP7 ANKRD11 MACF1 PRPF38A IQGAP3 | 5.22e-06 | 1497 | 172 | 22 | 31527615 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | CUL3 INTS1 DAPK1 WLS PAPSS1 MTIF2 USP7 KIF18B IQGAP3 TBCD HELLS | 5.48e-06 | 400 | 172 | 11 | 35013556 |
| Pubmed | CUL3 MYO6 PEG3 DDI2 LLGL1 MACF1 MORC3 UQCRH MVP ZRANB1 UQCRHL XRCC6 | 5.49e-06 | 481 | 172 | 12 | 28190767 | |
| Pubmed | 5.68e-06 | 24 | 172 | 4 | 24698270 | ||
| Pubmed | DOCK3 PPFIA4 PCDHA12 PCDHA3 CUL7 CELSR3 SYNJ2 SNX8 RPUSD2 CDH11 | 6.20e-06 | 329 | 172 | 10 | 17474147 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CUL3 UTP6 RRP1B UTP14A NOC3L CHD3 CUL7 RUVBL2 KIF20B MRPS22 MACF1 QARS1 ZRANB1 IQGAP3 XRCC6 | 6.21e-06 | 759 | 172 | 15 | 35915203 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 6.71e-06 | 332 | 172 | 10 | 32786267 | |
| Pubmed | DOCK3 MYO6 PPFIA4 SPTBN2 UTP14A CUL7 KHDC4 ZNF462 MACF1 MORC3 NUP160 KIF1C | 7.03e-06 | 493 | 172 | 12 | 15368895 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPSAP2 EPPK1 RRP1B LONP2 UTP14A RDX MCM6 RUVBL2 MRPS22 AP1G1 MDC1 SYNE2 MRPS14 USP7 MACF1 PLCB3 QARS1 DDX39B XRCC6 KIF1C HELLS | 7.50e-06 | 1415 | 172 | 21 | 28515276 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL3 DIP2B WAPL HIVEP1 CHD3 PPL ZFX CLASRP NCOR1 SHCBP1 MDC1 USP7 PLCB3 PRPF38A XRCC6 | 7.84e-06 | 774 | 172 | 15 | 15302935 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 9.49e-06 | 57 | 172 | 5 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 1.03e-05 | 58 | 172 | 5 | 30377227 | |
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 1.04e-05 | 150 | 172 | 7 | 30154076 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 1.08e-05 | 28 | 172 | 4 | 15347688 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DOCK3 EPPK1 NBPF20 NBPF19 NCOR1 EIF4ENIF1 NBPF9 CHD5 MDC1 USP7 NBPF14 | 1.08e-05 | 430 | 172 | 11 | 35044719 |
| Pubmed | 1.36e-05 | 104 | 172 | 6 | 9205841 | ||
| Pubmed | Comprehensive Proteomic Analysis of PGC7-Interacting Proteins. | 1.42e-05 | 287 | 172 | 9 | 28712289 | |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | WAPL RRP1B MYO6 UTP14A MCM6 RUVBL2 MRPS22 NCOR1 USP7 NUP160 DDX39B XRCC6 HELLS | 1.52e-05 | 624 | 172 | 13 | 33729478 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPPK1 RRP1B MYO6 SPTBN2 UTP14A NOC3L RDX MCM6 TGM3 LLGL1 CHD5 MDC1 USP7 MVP DDX39B XRCC6 | 2.16e-05 | 949 | 172 | 16 | 36574265 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RRP1B MYO6 SPTBN2 RDX MCM6 CHD3 NUF2 RUVBL2 MRPS22 CEP250 MRPS14 MACF1 QARS1 DDX39B XRCC6 | 2.25e-05 | 847 | 172 | 15 | 35235311 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 2.26e-05 | 68 | 172 | 5 | 11230163 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 36565314 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22389401 | ||
| Pubmed | Human UTP14a promotes angiogenesis through upregulating PDGFA expression in colorectal cancer. | 2.43e-05 | 2 | 172 | 2 | 30929921 | |
| Pubmed | No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer's disease. | 2.43e-05 | 2 | 172 | 2 | 18336955 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26510981 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 12645527 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 7700633 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22115042 | ||
| Pubmed | MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. | 2.43e-05 | 2 | 172 | 2 | 12607004 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22734645 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22357859 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 31253190 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 18412156 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 27094130 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26754263 | ||
| Pubmed | Characterising a homozygous two-exon deletion in UQCRH: comparing human and mouse phenotypes. | 2.43e-05 | 2 | 172 | 2 | 34750991 | |
| Pubmed | Structural delineation of MDC1-FHA domain binding with CHK2-pThr68. | 2.43e-05 | 2 | 172 | 2 | 22211259 | |
| Pubmed | PRPSAP2 EPPK1 GTPBP6 RRP1B PPFIA1 BAG1 RDX ITGA3 APP PAPSS1 NCOR1 MDC1 SYNE2 CHEK2 MACF1 QARS1 NUP160 XRCC6 HELLS | 2.51e-05 | 1297 | 172 | 19 | 33545068 | |
| Pubmed | 3.28e-05 | 13 | 172 | 3 | 29222402 | ||
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 3.41e-05 | 74 | 172 | 5 | 10817752 | |
| Pubmed | 3.51e-05 | 322 | 172 | 9 | 26514267 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.53e-05 | 123 | 172 | 6 | 26912792 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | WAPL EPPK1 PPFIA1 INTS1 CHD3 NUF2 RUVBL2 MACF1 MVP DDX39B XRCC6 HELLS | 3.60e-05 | 582 | 172 | 12 | 20467437 |
| Pubmed | MON2 FRAS1 PEG3 ZHX2 DENND11 ARFGEF3 MTMR3 MACF1 SH3BP5L USP33 | 3.84e-05 | 407 | 172 | 10 | 12693553 | |
| Pubmed | HIVEP1 MYO6 CHD3 PPL NCOR1 AP1G1 CEP250 MACF1 SPRED1 QARS1 XRCC6 TBCD | 4.18e-05 | 591 | 172 | 12 | 15231748 | |
| Pubmed | MON2 IFT140 WAPL PPFIA1 CHD3 ITGA3 CUL7 APP RUVBL2 SLC4A1 EIF4ENIF1 MTIF2 CHD5 USP7 MACF1 KIF18B TAF12 | 4.24e-05 | 1116 | 172 | 17 | 31753913 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CUL3 HIVEP1 MYO6 LONP2 NOC3L RDX MCM6 HIF1AN TGM3 GLDC SHCBP1 MRPS14 USP7 ZRANB1 NUP160 USP33 | 4.28e-05 | 1005 | 172 | 16 | 19615732 |
| Pubmed | BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. | 4.90e-05 | 419 | 172 | 10 | 33001583 | |
| Pubmed | CUL3 GTPBP6 MYO6 BAG1 DDI2 MRPS22 PARP10 LLGL1 USP7 PRPF38A MORC3 IQGAP3 | 5.15e-05 | 604 | 172 | 12 | 38803224 | |
| Pubmed | Lack of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal hydrocephalus. | 5.18e-05 | 15 | 172 | 3 | 20473291 | |
| Pubmed | 5.22e-05 | 339 | 172 | 9 | 30415952 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PRPSAP2 UTP6 EPPK1 MYO6 PMPCB MCM6 RUVBL2 MRPS22 AP1G1 PRPF38A IQGAP3 NUP160 DDX39B | 5.27e-05 | 704 | 172 | 13 | 29955894 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DIP2B PDE3B GTPBP6 RRP1B MYO6 PMPCB UTP14A NUF2 CUL7 MRPS22 ARFGEF3 EIF4ENIF1 MTIF2 SYNE2 MRPS14 MTMR3 NUP160 DDX39B XRCC6 USP33 | 5.47e-05 | 1496 | 172 | 20 | 32877691 |
| Pubmed | 6.36e-05 | 199 | 172 | 7 | 36688959 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CUL3 WAPL NUF2 PAPSS1 RUVBL2 MRPS22 PPL SYNJ2 SHCBP1 CHEK2 MORC3 IQGAP3 NUP160 DDX39B XRCC6 TBCD KIF1C | 6.47e-05 | 1155 | 172 | 17 | 20360068 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PMPCB PPFIA1 DAPK1 MRPS22 LLGL1 SYNJ2 STOML1 MRPS14 SNX8 MACF1 PRPF38A NUP160 TBCD | 6.52e-05 | 719 | 172 | 13 | 35337019 |
| Pubmed | Novel gene function revealed by mouse mutagenesis screens for models of age-related disease. | 6.72e-05 | 44 | 172 | 4 | 27534441 | |
| Pubmed | MON2 RRP1B PMPCB PPFIA1 DUSP4 SPTBN2 NOC3L CUL7 APP NCOR1 CRLF3 SYNE2 MTMR3 USP7 PRPF38A HELLS | 7.08e-05 | 1049 | 172 | 16 | 27880917 | |
| Pubmed | CUL3 IFT140 ABCA2 WAPL RRP1B PCDHA3 ADGRV1 CELSR3 SYNJ2 CHD5 MDC1 | 7.10e-05 | 529 | 172 | 11 | 14621295 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 27964702 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 27068745 | ||
| Interaction | NEK4 interactions | NBPF8 RPGRIP1 FRAS1 SETMAR ABCA2 NBPF12 RRP1B MYO6 PCDHA12 NBPF11 RUVBL2 NBPF1 ZNF462 NBPF15 CELSR3 ASXL3 NBPF9 MDC1 MTMR3 NBPF10 NBPF14 XRCC6 | 4.30e-09 | 582 | 170 | 22 | int:NEK4 |
| Interaction | MYO1B interactions | CUL3 DUSP4 STYK1 RDX DAPK1 CHD3 CUL7 EPB41L4A HIF1AN GLDC CHEK2 USP7 FGD5 ZRANB1 DDX39B | 1.15e-08 | 273 | 170 | 15 | int:MYO1B |
| Interaction | EED interactions | CUL3 UTP6 RRP1B MYO6 PEG3 UTP14A ZSCAN26 INTS1 NOC3L DAPK1 MCM6 CHD3 CUL7 RUVBL2 KIF20B CLASRP NCOR1 AP1G1 GLDC MDC1 SNX8 USP7 MACF1 PRPF38A MORC3 KIF18B MVP ZRANB1 NUP160 DDX39B XRCC6 TBCD HELLS | 1.31e-07 | 1445 | 170 | 33 | int:EED |
| Interaction | TOP3B interactions | MON2 DOCK3 FRAS1 ABCA2 EPPK1 GTPBP6 MYO6 SPTBN2 INTS1 ITGA3 APP SBNO2 NBPF1 NCOR1 CELSR1 SYNE3 EIF4ENIF1 CELSR3 CHD5 MDC1 SNX8 MTMR3 USP7 ANKRD11 AP1G2 ULK4 SH3BP5L QARS1 IQGAP3 DDX39B XRCC6 TBCD | 6.11e-07 | 1470 | 170 | 32 | int:TOP3B |
| Interaction | TMOD3 interactions | CUL3 RASA1 LONP2 DUSP4 ZSCAN26 DAPK1 CUL7 RUVBL2 FGD5 ZRANB1 DDX39B XRCC6 | 1.10e-06 | 243 | 170 | 12 | int:TMOD3 |
| Interaction | RBBP4 interactions | CUL3 BAG1 CHD3 CUL7 ZHX2 RUVBL2 CLASRP ZNF462 NCOR1 ASXL3 CHD5 CEP250 SHCBP1 USP7 ZRANB1 DDX39B XRCC6 FAM43A | 1.78e-06 | 573 | 170 | 18 | int:RBBP4 |
| Interaction | MKI67 interactions | CUL3 UTP6 FRAS1 LONP2 UTP14A NOC3L MCM6 CHD3 CUL7 KIF20B MRPS22 AP1G1 SHCBP1 MDC1 MRPS14 CHEK2 KIF18B ZRANB1 XRCC6 | 2.49e-06 | 648 | 170 | 19 | int:MKI67 |
| Interaction | MRGBP interactions | 4.01e-06 | 109 | 170 | 8 | int:MRGBP | |
| Interaction | SF3B3 interactions | CUL3 WAPL UTP14A BAG1 CHD3 CUL7 NCOR1 EIF4ENIF1 GLDC ASXL3 CHEK2 USP7 AP1G2 TAF12 ZRANB1 IQGAP3 DDX39B | 5.25e-06 | 558 | 170 | 17 | int:SF3B3 |
| Interaction | UQCRHL interactions | 5.82e-06 | 5 | 170 | 3 | int:UQCRHL | |
| Interaction | ADAR interactions | CUL3 WAPL INTS1 CHD3 CUL7 RUVBL2 GLDC CHD5 MDC1 USP7 ZRANB1 XRCC6 | 5.92e-06 | 286 | 170 | 12 | int:ADAR |
| Interaction | NUP43 interactions | HIVEP1 RRP1B NOC3L CHD3 CUL7 ZHX2 UBR7 ZFX ZNF462 NCOR1 EIF4ENIF1 CEP250 MDC1 SYNE2 ANKRD11 DNAH9 ZRANB1 NUP160 | 5.95e-06 | 625 | 170 | 18 | int:NUP43 |
| Interaction | PRPF40A interactions | CUL3 DZIP1L UTP14A CHD3 NUF2 CUL7 PHKG2 SYNE3 GLDC CHEK2 USP7 PRPF38A ZRANB1 DDX39B XRCC6 | 6.00e-06 | 446 | 170 | 15 | int:PRPF40A |
| Interaction | CORO1C interactions | CUL3 RASA1 DUSP4 RDX DAPK1 CUL7 PPL TGM3 GLDC UQCRH ZRANB1 DDX39B XRCC6 | 6.18e-06 | 338 | 170 | 13 | int:CORO1C |
| Interaction | ST13 interactions | 6.34e-06 | 195 | 170 | 10 | int:ST13 | |
| Interaction | ATP5F1B interactions | CUL3 ABCA2 PMPCB RDX CHD3 CUL7 OPRL1 EIF4ENIF1 GLDC MTIF2 ASXL3 CEP250 MACF1 FGD5 UQCRH ZRANB1 DDX39B XRCC6 | 6.36e-06 | 628 | 170 | 18 | int:ATP5F1B |
| Interaction | PCDHA8 interactions | 6.79e-06 | 55 | 170 | 6 | int:PCDHA8 | |
| Interaction | H3C1 interactions | WAPL RRP1B MYO6 INTS1 NOC3L MCM6 CHD3 RUVBL2 UBR7 KIF20B MRPS22 PARP10 NCOR1 SHCBP1 MDC1 USP7 MORC3 KIF18B DNAH9 ZRANB1 XRCC6 HELLS | 7.45e-06 | 901 | 170 | 22 | int:H3C1 |
| Interaction | RAB5A interactions | MON2 PRPSAP2 HIVEP1 RASA1 MYO6 ITGA3 WLS ARFGEF3 NCOR1 LLGL1 AP1G1 SYNE2 MACF1 UQCRH TAF12 QARS1 MVP ZRANB1 USP33 | 8.51e-06 | 706 | 170 | 19 | int:RAB5A |
| Interaction | KPNA2 interactions | CUL3 BAG1 MCM6 CHD3 CUL7 APP RUVBL2 EIF4ENIF1 MTIF2 ASXL3 CHEK2 FGD5 MORC3 KIF18B MVP ZRANB1 | 8.70e-06 | 519 | 170 | 16 | int:KPNA2 |
| Interaction | PEG3 interactions | 1.07e-05 | 17 | 170 | 4 | int:PEG3 | |
| Interaction | PCDHA11 interactions | 1.72e-05 | 19 | 170 | 4 | int:PCDHA11 | |
| Interaction | SIRT7 interactions | UTP6 EPPK1 RRP1B SPTBN2 UTP14A INTS1 NOC3L MCM6 CUL7 APP TGM3 MDC1 SYNE2 USP7 MACF1 MVP ZRANB1 NUP160 XRCC6 | 1.77e-05 | 744 | 170 | 19 | int:SIRT7 |
| Interaction | H3-3A interactions | CUL3 SDE2 WAPL HIVEP1 CAMKK1 RRP1B ZSCAN26 INTS1 CHD3 UBR7 KIF20B PARP10 CHD5 MDC1 USP7 MORC3 KIF18B XRCC6 HELLS | 1.94e-05 | 749 | 170 | 19 | int:H3-3A |
| Interaction | HSD17B10 interactions | CUL3 MYO6 PMPCB BAG1 RDX CHD3 CUL7 APP RUVBL2 MTIF2 ASXL3 FGD5 ZRANB1 XRCC6 | 1.97e-05 | 434 | 170 | 14 | int:HSD17B10 |
| Interaction | ABLIM1 interactions | 1.99e-05 | 177 | 170 | 9 | int:ABLIM1 | |
| Interaction | HBA1 interactions | 2.15e-05 | 67 | 170 | 6 | int:HBA1 | |
| Interaction | TRMT6 interactions | 2.70e-05 | 103 | 170 | 7 | int:TRMT6 | |
| Interaction | TOM1 interactions | 2.87e-05 | 104 | 170 | 7 | int:TOM1 | |
| Interaction | EFTUD2 interactions | CUL3 PRPSAP2 WAPL RRP1B LONP2 UTP14A RDX MCM6 CHD3 CUL7 RUVBL2 MRPS22 AP1G1 GLDC MDC1 SYNE2 MRPS14 CHEK2 USP7 RPUSD2 MACF1 PLCB3 QARS1 ZRANB1 DDX39B XRCC6 KIF1C HELLS | 3.12e-05 | 1449 | 170 | 28 | int:EFTUD2 |
| Interaction | DST interactions | STYK1 RDX EPB41L4A SYNE3 EIF4ENIF1 CELSR3 CEP250 USP7 FGD5 MORC3 ZRANB1 | 3.36e-05 | 287 | 170 | 11 | int:DST |
| Interaction | NUP50 interactions | CUL3 PMPCB DUSP4 UTP14A RDX APP NCOR1 EIF4ENIF1 KIF18B ZRANB1 NUP160 XRCC6 | 3.40e-05 | 341 | 170 | 12 | int:NUP50 |
| Interaction | PCBP2 interactions | CUL3 SETMAR BAG1 CHD3 CUL7 RUVBL2 ASXL3 CEP250 CHEK2 ZRANB1 XRCC6 | 3.47e-05 | 288 | 170 | 11 | int:PCBP2 |
| Interaction | XRCC6 interactions | CUL3 WAPL RASA1 RRP1B UTP14A INTS1 BAG1 CHD3 CUL7 RUVBL2 NCOR1 EIF4ENIF1 ASXL3 MDC1 CHEK2 FGD5 ZRANB1 DDX39B XRCC6 TBCD HELLS | 3.75e-05 | 928 | 170 | 21 | int:XRCC6 |
| Interaction | H2BC3 interactions | CUL3 WAPL EPPK1 MCM6 CHD3 APP RUVBL2 UBR7 MDC1 USP7 KIF18B QARS1 XRCC6 | 4.25e-05 | 406 | 170 | 13 | int:H2BC3 |
| Interaction | PPP2R5E interactions | 4.63e-05 | 112 | 170 | 7 | int:PPP2R5E | |
| Interaction | CD160 interactions | 5.14e-05 | 48 | 170 | 5 | int:CD160 | |
| Interaction | KPNB1 interactions | CUL3 BAG1 CHD3 CUL7 RUVBL2 KIF20B SYNE3 GLDC ASXL3 MDC1 CHEK2 KIF18B ZRANB1 NUP160 DDX39B | 6.04e-05 | 544 | 170 | 15 | int:KPNB1 |
| Interaction | DOCK7 interactions | CUL3 PRPSAP2 MYO6 DAPK1 HIF1AN CRLF3 CEP250 USP7 FGD5 ZRANB1 | 6.16e-05 | 254 | 170 | 10 | int:DOCK7 |
| Interaction | NASP interactions | 6.78e-05 | 207 | 170 | 9 | int:NASP | |
| Interaction | TERF2IP interactions | CUL3 SDE2 WAPL HIVEP1 UTP14A INTS1 CHD3 KIF20B NCOR1 MDC1 ANKRD11 RPUSD2 ZRANB1 XRCC6 HELLS | 7.11e-05 | 552 | 170 | 15 | int:TERF2IP |
| Interaction | H3C3 interactions | WAPL HIVEP1 RRP1B ZSCAN26 CHD3 UBR7 KIF20B ZNF462 CHD5 MDC1 MORC3 KIF18B XRCC6 HELLS | 8.19e-05 | 495 | 170 | 14 | int:H3C3 |
| Interaction | SPTAN1 interactions | MON2 CUL3 PPFIA1 SPTBN2 ZSCAN26 RDX DAPK1 EPB41L4A GLDC SYNE2 USP7 FGD5 ZRANB1 DDX39B | 8.37e-05 | 496 | 170 | 14 | int:SPTAN1 |
| Interaction | SIRT6 interactions | WAPL RRP1B NOC3L MCM6 CHD3 RUVBL2 CELSR1 CELSR3 MDC1 USP7 QARS1 ZRANB1 IQGAP3 NUP160 DDX39B XRCC6 | 8.66e-05 | 628 | 170 | 16 | int:SIRT6 |
| Interaction | CENPA interactions | HIVEP1 RRP1B NOC3L CHD3 RUVBL2 ZNF462 SHCBP1 ANKRD11 KIF18B NUP160 XRCC6 HELLS | 8.91e-05 | 377 | 170 | 12 | int:CENPA |
| Interaction | ENO1 interactions | CUL3 MYO6 PMPCB LONP2 NOC3L RDX CHD3 CUL7 NCOR1 ASXL3 CEP250 MDC1 CHEK2 FGD5 ZRANB1 DDX39B XRCC6 | 9.44e-05 | 701 | 170 | 17 | int:ENO1 |
| Interaction | UBE3A interactions | GNE PPFIA1 BAG1 DDI2 MCM6 APP RUVBL2 HIF1AN PHKG2 NBPF14 ZRANB1 DDX39B XRCC6 | 9.80e-05 | 441 | 170 | 13 | int:UBE3A |
| Interaction | CLK1 interactions | CUL3 HIVEP1 CYP46A1 CLASRP NCOR1 CELSR3 ASXL3 PRPF38A ZRANB1 | 1.04e-04 | 219 | 170 | 9 | int:CLK1 |
| Interaction | PHGDH interactions | CUL3 UTP14A BAG1 DDI2 CUL7 APP ASXL3 MDC1 USP7 ZRANB1 DDX39B XRCC6 | 1.09e-04 | 385 | 170 | 12 | int:PHGDH |
| Interaction | PARP1 interactions | CUL3 PRPSAP2 HIVEP1 RRP1B UTP14A INTS1 BAG1 NOC3L DAPK1 MCM6 CHD3 CUL7 WLS PAPSS1 RUVBL2 GLDC MTIF2 USP7 MORC3 KIF18B ZRANB1 IQGAP3 XRCC6 TBCD HELLS | 1.15e-04 | 1316 | 170 | 25 | int:PARP1 |
| Interaction | PKP2 interactions | 1.28e-04 | 225 | 170 | 9 | int:PKP2 | |
| Interaction | RPAP3 interactions | 1.28e-04 | 225 | 170 | 9 | int:RPAP3 | |
| Interaction | RNASEH2B interactions | 1.29e-04 | 58 | 170 | 5 | int:RNASEH2B | |
| Interaction | MATR3 interactions | CUL3 WAPL EPPK1 UTP14A BAG1 MCM6 CHD3 CUL7 RUVBL2 NCOR1 GLDC CEP250 USP7 ZRANB1 DDX39B XRCC6 | 1.41e-04 | 655 | 170 | 16 | int:MATR3 |
| Interaction | SCO2 interactions | 1.44e-04 | 134 | 170 | 7 | int:SCO2 | |
| Interaction | MYO1C interactions | CUL3 RASA1 MYO6 DUSP4 SPTBN2 ZSCAN26 STYK1 DAPK1 GLDC FGD5 ZRANB1 DDX39B | 1.45e-04 | 397 | 170 | 12 | int:MYO1C |
| Interaction | IVNS1ABP interactions | 1.48e-04 | 180 | 170 | 8 | int:IVNS1ABP | |
| Interaction | MTNR1B interactions | 1.50e-04 | 135 | 170 | 7 | int:MTNR1B | |
| Interaction | SRRT interactions | 1.53e-04 | 340 | 170 | 11 | int:SRRT | |
| Interaction | RNMT interactions | 1.54e-04 | 95 | 170 | 6 | int:RNMT | |
| Interaction | ZSCAN2 interactions | 1.58e-04 | 13 | 170 | 3 | int:ZSCAN2 | |
| Interaction | EHF interactions | 1.58e-04 | 13 | 170 | 3 | int:EHF | |
| Interaction | KRT4 interactions | 1.77e-04 | 62 | 170 | 5 | int:KRT4 | |
| Interaction | NNT interactions | 1.79e-04 | 185 | 170 | 8 | int:NNT | |
| Interaction | MRPS2 interactions | 1.83e-04 | 290 | 170 | 10 | int:MRPS2 | |
| Interaction | ANKRA2 interactions | 1.86e-04 | 34 | 170 | 4 | int:ANKRA2 | |
| Interaction | SF3A1 interactions | CUL3 DUSP4 UTP14A BAG1 MCM6 CHD3 CUL7 NCOR1 ASXL3 MDC1 ZRANB1 DDX39B XRCC6 | 1.88e-04 | 471 | 170 | 13 | int:SF3A1 |
| Interaction | EPB41L4A interactions | 1.88e-04 | 140 | 170 | 7 | int:EPB41L4A | |
| Interaction | ERC1 interactions | 1.93e-04 | 187 | 170 | 8 | int:ERC1 | |
| Interaction | PRR15 interactions | 2.00e-04 | 14 | 170 | 3 | int:PRR15 | |
| Interaction | GAK interactions | 2.07e-04 | 189 | 170 | 8 | int:GAK | |
| Interaction | RPUSD2 interactions | 2.09e-04 | 35 | 170 | 4 | int:RPUSD2 | |
| Interaction | CAPZB interactions | CUL3 PRPSAP2 RASA1 MYO6 PPFIA1 BAG1 DAPK1 CUL7 PAPSS1 RUVBL2 UBR7 MRPS22 EIF4ENIF1 SHCBP1 MDC1 USP7 FGD5 QARS1 ZRANB1 DDX39B XRCC6 | 2.10e-04 | 1049 | 170 | 21 | int:CAPZB |
| Interaction | MYH9 interactions | CUL3 HIVEP1 MYO6 PMPCB SPTBN2 BAG1 CHD3 RUVBL2 GLDC CEP250 USP7 MACF1 FGD5 MVP ZRANB1 DDX39B XRCC6 | 2.25e-04 | 754 | 170 | 17 | int:MYH9 |
| Interaction | TUFM interactions | CUL3 GTPBP6 MYO6 BAG1 RDX CUL7 APP MRPS22 AP1G1 MTIF2 ASXL3 MRPS14 MACF1 FGD5 ZRANB1 DDX39B | 2.37e-04 | 686 | 170 | 16 | int:TUFM |
| Interaction | ZKSCAN1 interactions | 2.37e-04 | 66 | 170 | 5 | int:ZKSCAN1 | |
| Interaction | CCT8 interactions | CUL3 BAG1 RDX DDI2 CUL7 APP HIF1AN ASXL3 MACF1 FGD5 QARS1 ZRANB1 DDX39B XRCC6 | 2.45e-04 | 550 | 170 | 14 | int:CCT8 |
| Interaction | KLF12 interactions | 2.48e-04 | 194 | 170 | 8 | int:KLF12 | |
| Interaction | KCTD18 interactions | 2.49e-04 | 15 | 170 | 3 | int:KCTD18 | |
| Interaction | JUP interactions | RASA1 MYO6 DUSP4 STYK1 CHD3 CUL7 EPB41L4A RUVBL2 GLDC PTPRQ ZRANB1 DDX39B XRCC6 | 2.49e-04 | 485 | 170 | 13 | int:JUP |
| Interaction | WDCP interactions | 2.53e-04 | 104 | 170 | 6 | int:WDCP | |
| Interaction | MACF1 interactions | 2.57e-04 | 247 | 170 | 9 | int:MACF1 | |
| Interaction | TRIM28 interactions | CUL3 PRPSAP2 UTP6 EPPK1 RRP1B MYO6 PMPCB BAG1 MCM6 CHD3 CUL7 RUVBL2 MRPS22 ZNF462 NCOR1 AP1G1 CEP250 MDC1 SNX8 CHEK2 PRPF38A ZRANB1 IQGAP3 NUP160 DDX39B XRCC6 | 2.68e-04 | 1474 | 170 | 26 | int:TRIM28 |
| Interaction | USP14 interactions | RRP1B MYO6 SPTBN2 UTP14A BAG1 DDI2 MDC1 USP7 MACF1 QARS1 ZRANB1 NUP160 XRCC6 | 2.70e-04 | 489 | 170 | 13 | int:USP14 |
| Interaction | ASF1A interactions | 2.73e-04 | 249 | 170 | 9 | int:ASF1A | |
| Interaction | DDX17 interactions | CUL3 BAG1 CHD3 CUL7 APP GLDC CEP250 USP7 QARS1 ZRANB1 DDX39B XRCC6 | 2.76e-04 | 426 | 170 | 12 | int:DDX17 |
| Interaction | RIT1 interactions | UTP6 SDE2 PMPCB PPFIA1 INTS1 GINS4 MCM6 NUF2 ITGA3 RUVBL2 NBPF20 CLASRP NBPF15 MRPS14 NBPF10 USP7 PRPF38A QARS1 NBPF14 NUP160 UQCRHL XRCC6 TBCD | 2.77e-04 | 1230 | 170 | 23 | int:RIT1 |
| Interaction | DVL2 interactions | CUL3 FRAS1 RDX ADGRV1 EPB41L4A AP1G1 SNX8 CHEK2 USP7 MACF1 ZRANB1 IQGAP3 XRCC6 DNAH11 | 2.78e-04 | 557 | 170 | 14 | int:DVL2 |
| Interaction | CALM1 interactions | DOCK3 CUL3 CAMKK1 RASA1 MYO6 BAG1 RDX DAPK1 CUL7 PHKG2 SYNE2 CHEK2 IQGAP3 DDX39B KIF1C | 2.80e-04 | 626 | 170 | 15 | int:CALM1 |
| Interaction | C2orf49 interactions | 2.88e-04 | 38 | 170 | 4 | int:C2orf49 | |
| Interaction | MRPS18B interactions | CUL3 PMPCB CUL7 MRPS22 LRP10 MTIF2 CEP250 MRPS14 QARS1 ZRANB1 | 2.89e-04 | 307 | 170 | 10 | int:MRPS18B |
| Interaction | PGAM1 interactions | 2.94e-04 | 199 | 170 | 8 | int:PGAM1 | |
| Interaction | TRIM37 interactions | CUL3 RPGRIP1 EPPK1 MYO6 DZIP1L UTP14A RDX NCOR1 TGM3 SYNE3 CEP250 ANKRD11 MVP DDX39B XRCC6 | 3.00e-04 | 630 | 170 | 15 | int:TRIM37 |
| Interaction | PLEC interactions | CUL3 DUSP4 CUL7 SYNE3 GLDC SYNE2 USP7 MACF1 FGD5 QARS1 ZRANB1 DDX39B | 3.01e-04 | 430 | 170 | 12 | int:PLEC |
| Interaction | TBCC interactions | 3.05e-04 | 16 | 170 | 3 | int:TBCC | |
| Interaction | H4C9 interactions | 3.10e-04 | 108 | 170 | 6 | int:H4C9 | |
| Interaction | ARMC5 interactions | 3.14e-04 | 201 | 170 | 8 | int:ARMC5 | |
| Interaction | PKM interactions | CUL3 DAPK1 CUL7 APP ASXL3 SYNE2 CHEK2 USP7 FGD5 FRMPD3 ZRANB1 DDX39B HELLS | 3.15e-04 | 497 | 170 | 13 | int:PKM |
| Interaction | CDC5L interactions | CUL3 UTP6 EPPK1 PPFIA1 UTP14A INTS1 CHD3 NUF2 CUL7 RUVBL2 KHDC4 MDC1 USP7 MACF1 MVP ZRANB1 DDX39B HELLS | 3.36e-04 | 855 | 170 | 18 | int:CDC5L |
| Interaction | KRT9 interactions | 3.51e-04 | 155 | 170 | 7 | int:KRT9 | |
| Cytoband | 1q21.1 | 3.79e-06 | 62 | 172 | 5 | 1q21.1 | |
| Cytoband | 5q31 | 5.09e-06 | 115 | 172 | 6 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | NBPF12 NUP210L NBPF11 NBPF20 NBPF19 NBPF15 NBPF9 NBPF10 NBPF14 | 2.41e-05 | 404 | 172 | 9 | chr1q21 |
| GeneFamily | Neuroblastoma breakpoint family | NBPF8 NBPF12 NBPF26 NBPF11 NBPF20 NBPF1 NBPF19 NBPF15 NBPF9 NBPF10 NBPF14 | 3.57e-19 | 23 | 111 | 11 | 662 |
| GeneFamily | EF-hand domain containing|Plakins | 1.23e-05 | 8 | 111 | 3 | 939 | |
| GeneFamily | Clustered protocadherins | 4.55e-05 | 64 | 111 | 5 | 20 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.12e-04 | 3 | 111 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.12e-04 | 3 | 111 | 2 | 1189 | |
| GeneFamily | DNA helicases | 1.44e-04 | 17 | 111 | 3 | 1167 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.22e-04 | 4 | 111 | 2 | 1252 | |
| GeneFamily | Cullins | 1.02e-03 | 8 | 111 | 2 | 1032 | |
| GeneFamily | PHD finger proteins|NuRD complex | 2.37e-03 | 12 | 111 | 2 | 1305 | |
| GeneFamily | CD molecules|Type II classical cadherins | 2.79e-03 | 13 | 111 | 2 | 1186 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.82e-03 | 46 | 111 | 3 | 622 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.58e-03 | 50 | 111 | 3 | 1293 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.72e-03 | 15 | 111 | 2 | 529 | |
| GeneFamily | Dyneins, axonemal | 4.78e-03 | 17 | 111 | 2 | 536 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 5.97e-03 | 19 | 111 | 2 | 832 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | WAPL HIVEP1 RASA1 GNE PPFIA1 DUSP4 RDX DAPK1 APP ZHX2 KIF20B TGFBR3 SYNJ2 MTIF2 SYNE2 MTMR3 USP7 MACF1 NBPF14 NUP160 | 8.71e-07 | 856 | 171 | 20 | M4500 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | GINS4 MCM6 NUF2 KIF20B SHCBP1 SYNE2 CHEK2 KIF18B IQGAP3 HELLS | 6.16e-09 | 200 | 172 | 10 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | GINS4 MCM6 NUF2 KIF20B SHCBP1 SYNE2 CHEK2 KIF18B IQGAP3 HELLS | 6.16e-09 | 200 | 172 | 10 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.56e-08 | 193 | 172 | 9 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.16e-08 | 198 | 172 | 9 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-07 | 184 | 172 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-07 | 184 | 172 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-07 | 184 | 172 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.91e-07 | 187 | 172 | 8 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.79e-07 | 190 | 172 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.43e-07 | 192 | 172 | 8 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.76e-07 | 193 | 172 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.11e-07 | 194 | 172 | 8 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 9.84e-07 | 196 | 172 | 8 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.84e-07 | 196 | 172 | 8 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.84e-07 | 196 | 172 | 8 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.02e-06 | 197 | 172 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 1.06e-06 | 198 | 172 | 8 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-06 | 199 | 172 | 8 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | severe-Lymphocytic-Prol._cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.10e-06 | 199 | 172 | 8 | b24315952b6ac6c8d2d3a7bd949a5b5392624d4e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.14e-06 | 200 | 172 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | PSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-06 | 200 | 172 | 8 | 3e3de496508efb2f95e5e8684f97687381e96493 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-06 | 200 | 172 | 8 | 2afbb5b5742b956993796621fea7e0c9888754a1 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class | 1.14e-06 | 200 | 172 | 8 | f277db6cc288a52a5426120c1067608700ee8ccc | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-06 | 200 | 172 | 8 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-06 | 200 | 172 | 8 | 4462ebd5d4632788f10a93fadd2babae701c754f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-06 | 200 | 172 | 8 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.44e-06 | 155 | 172 | 7 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-06 | 162 | 172 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.69e-06 | 165 | 172 | 7 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.67e-06 | 171 | 172 | 7 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.24e-06 | 174 | 172 | 7 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.24e-06 | 174 | 172 | 7 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.78e-06 | 181 | 172 | 7 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.78e-06 | 181 | 172 | 7 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.78e-06 | 181 | 172 | 7 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-06 | 182 | 172 | 7 | 22d6f4790950508e8aa27e02a8133af5f53f13c8 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 7.55e-06 | 184 | 172 | 7 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.55e-06 | 184 | 172 | 7 | 6b2449ac65a2322aa0479fba0d89828f243aabbe | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.55e-06 | 184 | 172 | 7 | e90622b82fa7f16a1faaf7a4724c958f2d83341d | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.39e-06 | 187 | 172 | 7 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-06 | 187 | 172 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-06 | 187 | 172 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.39e-06 | 187 | 172 | 7 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-06 | 187 | 172 | 7 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.69e-06 | 188 | 172 | 7 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.99e-06 | 189 | 172 | 7 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.99e-06 | 189 | 172 | 7 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 9.31e-06 | 190 | 172 | 7 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.63e-06 | 191 | 172 | 7 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 9.63e-06 | 191 | 172 | 7 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.63e-06 | 191 | 172 | 7 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-06 | 192 | 172 | 7 | ec1fd2fb6e71f87189d66261909a84e2be63cacb | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 194 | 172 | 7 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 194 | 172 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 194 | 172 | 7 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-05 | 195 | 172 | 7 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.10e-05 | 195 | 172 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-05 | 195 | 172 | 7 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.14e-05 | 196 | 172 | 7 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-05 | 196 | 172 | 7 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.14e-05 | 196 | 172 | 7 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.14e-05 | 196 | 172 | 7 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-05 | 196 | 172 | 7 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.14e-05 | 196 | 172 | 7 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-05 | 196 | 172 | 7 | 0c003a767c3b58605099dab64b9df0d8e5d8bc4b | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.14e-05 | 196 | 172 | 7 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 197 | 172 | 7 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Control-Myeloid-proliferating_Myeloid_cells|Control / Disease group,lineage and cell class (2021.01.30) | 1.18e-05 | 197 | 172 | 7 | ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 197 | 172 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.18e-05 | 197 | 172 | 7 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 198 | 172 | 7 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.22e-05 | 198 | 172 | 7 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.22e-05 | 198 | 172 | 7 | f9f083c76c51b6f014ecf80eaec957eff8d1ab75 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 198 | 172 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-05 | 198 | 172 | 7 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-05 | 198 | 172 | 7 | ddec07c7bc26d35f155537d907b46e2cb5b55b5f | |
| ToppCell | TCGA-Lung-Primary_Tumor|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.26e-05 | 199 | 172 | 7 | d1d035e987280607266171094db5d6362efe1ad5 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.26e-05 | 199 | 172 | 7 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.26e-05 | 199 | 172 | 7 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.26e-05 | 199 | 172 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 1.26e-05 | 199 | 172 | 7 | 2e222e2e080bc2be63d0fdf285e1790676b911ef | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.26e-05 | 199 | 172 | 7 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-05 | 199 | 172 | 7 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 199 | 172 | 7 | 88d130e2451e61afb710edf552e6b346b9fcfb2b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.26e-05 | 199 | 172 | 7 | 6748d4f76703360071d5f2026d9d06bf30ccfb6d | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.26e-05 | 199 | 172 | 7 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Proliferating_Epithelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.26e-05 | 199 | 172 | 7 | d73667e2e93026d95184e24ff0bc90afd1fb74a9 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 199 | 172 | 7 | e3b69608c834bd8ce6bedde298a2763cc0d7d573 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.26e-05 | 199 | 172 | 7 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.30e-05 | 200 | 172 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Biopsy_IPF-Epithelial-Proliferating_Epithelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.30e-05 | 200 | 172 | 7 | 63c5402f050fdb12abab3c8b7f33d4914ae26b9b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 200 | 172 | 7 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.30e-05 | 200 | 172 | 7 | 87e293c0882e2754756a2210a6c04723dc89f81b | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.30e-05 | 200 | 172 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.30e-05 | 200 | 172 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Transverse / Region, Cell class and subclass | 1.30e-05 | 200 | 172 | 7 | f588d8889f351c797963616a3575fa43efd46b9a | |
| ToppCell | Biopsy_IPF-Epithelial|Biopsy_IPF / Sample group, Lineage and Cell type | 1.30e-05 | 200 | 172 | 7 | 76f1ac00b34d07057d8da03d276438b719b46b1d | |
| ToppCell | Transverse-(5)_Dendritic_cell-(52)_cycling_DCs|Transverse / shred on region, Cell_type, and subtype | 1.30e-05 | 200 | 172 | 7 | 51e643d48b5e97a0e117b578a6ea7d429c6cdd1e | |
| ToppCell | Biopsy_IPF-Immune-Proliferating_Macrophages|Biopsy_IPF / Sample group, Lineage and Cell type | 1.30e-05 | 200 | 172 | 7 | 8abb2c25422717e994468ac02d8260344341467f | |
| ToppCell | distal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.30e-05 | 200 | 172 | 7 | 1b65c97e8123d0572d31525d6a10bc7f16857959 | |
| Drug | Pesticides | 1.78e-06 | 150 | 168 | 9 | ctd:D010575 | |
| Disease | 1,5 anhydroglucitol measurement | 1.65e-05 | 29 | 157 | 4 | EFO_0008009 | |
| Disease | age-related hearing impairment | 6.34e-05 | 324 | 157 | 9 | EFO_0005782 | |
| Disease | Malignant neoplasm of breast | PDGFA BAG1 C4orf50 FSCB MRPS22 CLASRP NCOR1 LLGL1 SYNJ2 CHD5 SYNE2 CHEK2 MTMR3 MACF1 FGD5 DNAH9 | 2.06e-04 | 1074 | 157 | 16 | C0006142 |
| Disease | apolipoprotein B measurement | PDE3B PMPCB DUSP4 CLASRP PARP10 LLGL1 AP1G1 SYNE2 SNX8 PLCB3 UQCRHL DNAH11 | 2.37e-04 | 663 | 157 | 12 | EFO_0004615 |
| Disease | response to surgery, post-operative sign or symptom | 4.16e-04 | 6 | 157 | 2 | EFO_0005323, EFO_0009951 | |
| Disease | squamous cell carcinoma | 4.56e-04 | 67 | 157 | 4 | EFO_0000707 | |
| Disease | HDL cholesterol change measurement, response to simvastatin, response to fenofibrate | 7.71e-04 | 8 | 157 | 2 | EFO_0007805, GO_1901557, GO_1903491 | |
| Disease | Nonsyndromic Deafness | 9.34e-04 | 81 | 157 | 4 | C3711374 | |
| Disease | visceral adipose tissue measurement, body mass index | 1.22e-03 | 87 | 157 | 4 | EFO_0004340, EFO_0004765 | |
| Disease | serum albumin measurement | DOCK3 FAM234B HIVEP1 ADGRV1 SLC39A13 PARP10 PHKG2 LLGL1 SNX8 MACF1 | 1.32e-03 | 592 | 157 | 10 | EFO_0004535 |
| Disease | childhood gender nonconformity | 1.56e-03 | 43 | 157 | 3 | EFO_0020103 | |
| Disease | AL amyloidosis | 1.79e-03 | 12 | 157 | 2 | MONDO_0019438 | |
| Disease | Primary Ciliary Dyskinesia | 2.02e-03 | 47 | 157 | 3 | C4551720 | |
| Disease | lymphocyte count | FRAS1 HIVEP1 EPPK1 PPFIA1 NOC3L JPH2 SBNO2 SLC4A1 OPRL1 NCOR1 CRLF3 CHEK2 PCDHGB4 USP7 ANKRD11 MORC3 NUP160 | 2.11e-03 | 1464 | 157 | 17 | EFO_0004587 |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 2.11e-03 | 13 | 157 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.27e-03 | 103 | 157 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | sexual dimorphism measurement | DOCK3 DIP2B EPPK1 KCTD19 SLC4A1 ZNF462 PARP10 CRLF3 CEP250 ANKRD11 ULK4 MACF1 ZSCAN2 PLCB3 | 2.42e-03 | 1106 | 157 | 14 | EFO_0021796 |
| Disease | multiple myeloma, monoclonal gammopathy | 2.45e-03 | 14 | 157 | 2 | EFO_0000203, EFO_0001378 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 2.55e-03 | 51 | 157 | 3 | cv:CN043650 | |
| Disease | cortical thickness | MON2 DIP2B NUP210L SPTBN2 ADGRV1 WLS HIF1AN KIF20B ZNF462 CELSR1 MTMR3 PCDHGB4 MACF1 CDH11 | 2.56e-03 | 1113 | 157 | 14 | EFO_0004840 |
| Disease | response to olanzapine | 2.82e-03 | 15 | 157 | 2 | GO_0097333 | |
| Disease | neutrophil count | HIVEP1 NUP210L PCDHA13 PCDHA12 MCM6 PCDHA3 NUF2 SBNO2 LRP10 MRPS14 CHEK2 NBPF10 ANKRD11 NUP160 FAM43A HELLS | 2.93e-03 | 1382 | 157 | 16 | EFO_0004833 |
| Disease | prostate carcinoma | IFT140 KCTD19 MYO6 TNC DUSP4 CHD3 NUF2 SLC39A13 PPL SYNE2 CHEK2 DNAH11 | 3.00e-03 | 891 | 157 | 12 | EFO_0001663 |
| Disease | hematocrit | HIVEP1 CHD3 ADGRV1 EPB41L4A SLC4A1 ZNF462 LLGL1 NME5 MTMR3 ULK4 PLCB3 FGD5 NUP160 | 3.02e-03 | 1011 | 157 | 13 | EFO_0004348 |
| Disease | Abnormality of refraction | DOCK3 RPGRIP1 RRP1B PCDHA13 PCDHA12 PCDHA3 ZNF462 MTMR3 RPUSD2 ULK4 | 3.34e-03 | 673 | 157 | 10 | HP_0000539 |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.05e-03 | 121 | 157 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.42e-03 | 200 | 157 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 4.53e-03 | 19 | 157 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | unipolar depression, response to bupropion, mood disorder | 4.53e-03 | 19 | 157 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | hydrocephalus (implicated_via_orthology) | 4.53e-03 | 19 | 157 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | non-lobar intracerebral hemorrhage | 4.65e-03 | 63 | 157 | 3 | EFO_0010178 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVLRTQEAVAEEDPI | 1266 | Q5RHP9 | |
| VEDIQRLVPDSDVEE | 1066 | P53355 | |
| LPVVEAENRRLEAEI | 296 | Q96LX7 | |
| ALEAAVEAETVPEER | 2216 | Q6UB99 | |
| EVQALPAALDRVESE | 1591 | Q8TDI0 | |
| RLQEAAELEAVELPV | 246 | P02730 | |
| REEEELDPRIQEELE | 51 | Q7L8J4 | |
| VPAVAEEIQDEVDEL | 551 | P05067 | |
| RFEVNISELPDEIDI | 406 | Q13838 | |
| EVLADDVPEIEEVIQ | 2306 | Q8WXG9 | |
| DVPEIEEVIQVQLTD | 2311 | Q8WXG9 | |
| IEPLQVDEEEVLALL | 496 | O75843 | |
| DVILIENLEETIDPV | 3536 | Q96DT5 | |
| SEPVVQDLAQVVEEV | 166 | Q99933 | |
| ERPVLVEFALLEVEE | 2391 | Q9NYQ6 | |
| AREADPALNVETEIE | 261 | O96017 | |
| DILIPEESVIQEEIA | 441 | Q9C0F0 | |
| EEEEELVDPLTTVRE | 21 | A0A096LP55 | |
| EEEEELVDPLTTVRE | 21 | P07919 | |
| IVEDLVEEVGREEDP | 331 | P20936 | |
| NIDVLEAEVEILEIP | 231 | Q17RG1 | |
| EAEVEILEIPALTEA | 236 | Q17RG1 | |
| VEVEVIDENDNAPEV | 331 | Q9UN71 | |
| DDPQALAVLLEEELV | 356 | Q15334 | |
| PEDVSEELIQEITQR | 86 | P35241 | |
| EPIQVTEDEVLDILE | 496 | O43747 | |
| QEQPVEEVLEELRAK | 201 | Q8IYY4 | |
| PELEARIDAVNAETI | 436 | O75439 | |
| IIRVETPDVNLDQEE | 656 | Q14566 | |
| VLLEIVDINDNVPEL | 336 | Q9Y5H8 | |
| QPEVDRERAVVEVNI | 536 | Q9NRZ9 | |
| RERAVVEVNIPVESE | 541 | Q9NRZ9 | |
| AAEAEVEVEEVPNTI | 661 | Q9BR39 | |
| LDIRDDDNPQDVVIE | 1241 | Q86XX4 | |
| AVLALEDEDDVLLVP | 681 | Q7Z4F1 | |
| IAEVEQLDRLEEFPN | 121 | Q86WA8 | |
| DVEEEELPVENREAV | 456 | Q14676 | |
| ILEVESEPRAREVVD | 431 | P46199 | |
| EVLPTVLLDEIEAAE | 116 | Q8N201 | |
| VREAAIELPESVQDV | 101 | Q5H9T9 | |
| EDELREEVTVPVVQE | 231 | Q5H9T9 | |
| EVDVIPEDGAADVRV | 486 | O43824 | |
| RAEELIENEEPVVLT | 51 | Q9NWT6 | |
| VVKLIEVLDDPAEDN | 211 | Q8N5S9 | |
| AETLPEVEAELAQRI | 361 | O75335 | |
| VDIDSELVEELPAEI | 976 | P26006 | |
| EDEIDVRNDAVILPS | 656 | Q14149 | |
| LERLDSVPVEEQEEF | 166 | Q9BZD4 | |
| EVLRIEPDRAQADEV | 996 | O60437 | |
| LPQADEIQVIEEADE | 1096 | Q13370 | |
| ELEPELLLQEARENV | 6 | Q8IUI8 | |
| DDEILAELAVPIELA | 526 | Q14999 | |
| VVVLPDLDEDGVRDL | 261 | A2RU67 | |
| PDVVVVLEEEALDDA | 411 | Q6ZNL6 | |
| PDIVDKEEEIQDIIL | 21 | P56597 | |
| EVRPNIAEIEDIRVL | 866 | Q96Q89 | |
| DERIVVVAEQRPDAS | 856 | Q9P265 | |
| EDPNARLIRELQEEV | 356 | O43896 | |
| ETLPEVEAELAQRVA | 386 | Q13136 | |
| DTEPEIIEETNIDRV | 1506 | Q6ZVL6 | |
| NLEENEIVDVPVEKL | 126 | Q8TCA0 | |
| VAEDERHRDIIEQPV | 181 | Q7Z3U7 | |
| ELDSQRRPVVQVVDE | 21 | Q86Y91 | |
| SRELLEAVEPEVLQD | 1041 | Q3BBV0 | |
| EVTAERLSPEQLEEV | 56 | P15735 | |
| ALEVVDDALERQSPE | 296 | Q86VI3 | |
| VEVVEERQAIPLDEN | 371 | Q14764 | |
| RIQGLNVEAAEPEVE | 1386 | Q9GZU2 | |
| VLDPAERAVVRVADE | 61 | Q9UPN3 | |
| PQDVEVIDVTADEIR | 711 | Q9UMZ3 | |
| LLVEVLDVNDNAPEV | 336 | Q9Y5I0 | |
| VLVDIVDVNDNAPEV | 351 | Q9Y5I4 | |
| EVPLRDVLEAIAETA | 386 | Q01970 | |
| VVELLQERDIVPVDA | 216 | O43252 | |
| EAEVTEEDPRLRAQQ | 6 | Q6ZRC1 | |
| VERRELVEVSPLENA | 1496 | Q8IZD9 | |
| VQDVDVVVSDLVDPA | 691 | Q9Y223 | |
| QPEIVARLQAEVDEV | 321 | Q9Y6A2 | |
| EIEREIIKQEENVDP | 1301 | Q12873 | |
| PTLVQLEEEIEEEVR | 166 | Q8NHY3 | |
| IVAINEEDVSEAPRE | 96 | Q5JV73 | |
| RLELGDVEEDQVVAV | 66 | A4D1U4 | |
| IQQETDIPERELVRA | 616 | Q13618 | |
| VLETEAVDQPDVVQR | 551 | Q5TH69 | |
| VEEPNLDELLVRLEE | 91 | Q9BV73 | |
| EPLIVFEEEDVRENI | 646 | P55287 | |
| PVEDDVDVASERQRV | 2026 | Q9BZC7 | |
| DIREDDNIAIIDVPV | 116 | O43736 | |
| PAEEEAEAQRALVVA | 291 | Q8N2R8 | |
| VPDVVQAAEDADILI | 76 | P21695 | |
| KEPLIISEEDVRENV | 641 | Q13634 | |
| DLVVAEVEINDVPLT | 101 | Q7Z7F0 | |
| APRRIEESAIDEVVV | 306 | O60256 | |
| AVVLIENLEESIDPV | 3506 | Q9NYC9 | |
| EEILERVTDEFNIPE | 4226 | Q9NYC9 | |
| EDVRPEEIADQELAE | 371 | Q5TDH0 | |
| EIQVVAPLDFEAERE | 601 | Q9NYQ7 | |
| VSLEQILPAEEEVRA | 81 | Q13115 | |
| VPDQKEELEEAIERI | 166 | Q9HCS5 | |
| GERVAEVAPEERENV | 351 | Q6IQ49 | |
| EVAPEERENVAVAKL | 356 | Q6IQ49 | |
| RVEEPLENDISQLVD | 66 | Q9NV23 | |
| IALVNVLPDLLEEED | 331 | Q96H72 | |
| LREAEQEPELEARVA | 836 | Q96RY7 | |
| EDSLEVPVEQFRIEE | 786 | Q13615 | |
| DVELLLVDDVTVVPE | 891 | Q5VU65 | |
| AVDDRDEAQPEVIVL | 536 | Q68BL7 | |
| VLVEVLDVNDNVPEV | 336 | Q9UN75 | |
| PLSEADVRVLEEQAQ | 141 | Q53GL7 | |
| LEEEIIEDPIQELTI | 186 | Q8WTT2 | |
| LDRDLQEDEVPVVGI | 311 | Q86XP0 | |
| AQVEDEEIECLVEIP | 191 | P41146 | |
| VLEERVPINDVLAED | 131 | P82650 | |
| EIIEGEVVEIQIDRP | 136 | Q9Y230 | |
| EPIRLLAENEDVVVV | 221 | Q8IZ73 | |
| IVTPEQIEEAVEAAI | 116 | P47897 | |
| QERIEDRLPELEQLE | 6 | Q9NYH9 | |
| RDILEQELDIVSPED | 1241 | Q96KN7 | |
| AEEIPENEVSLRRAV | 246 | Q14684 | |
| PESVEQLESRIVEQE | 366 | Q9Y5X2 | |
| IRVEEEVAPRQEDLV | 26 | A2VEC9 | |
| RERQENILVEPDTDE | 176 | Q9BRT9 | |
| EAIILDNLQEELPEI | 3481 | Q8WXH0 | |
| EGAAVVQEELRELAE | 721 | Q6ZMZ3 | |
| RPVLAIVEVEVQEVD | 856 | O15056 | |
| RELLEVVEPEVLQDS | 736 | Q3BBV2 | |
| RELLEVVEPEVLQDS | 771 | P0DPF3 | |
| ELLEVVEPEVLQDSL | 941 | P0DPF3 | |
| RELLEVVEPEVLQDS | 771 | Q6P3W6 | |
| ELLEVVEPEVLQDSL | 1016 | Q6P3W6 | |
| LEVVEPEVLQDSLDR | 1506 | Q6P3W6 | |
| SRELLEVVEPEVLQD | 1746 | Q6P3W6 | |
| EVVEPEVLQDSLDRC | 1751 | Q6P3W6 | |
| RELLEVVEPEVLQDS | 1991 | Q6P3W6 | |
| ELLEVVEPEVLQDSL | 2236 | Q6P3W6 | |
| LEVVEPEVLQDSLDR | 2726 | Q6P3W6 | |
| SRELLEVVEPEVLQD | 2966 | Q6P3W6 | |
| EVVEPEVLQDSLDRC | 2971 | Q6P3W6 | |
| RELLEVVEPEVLQDS | 3211 | Q6P3W6 | |
| ELLEVVEPEVLQDSL | 3456 | Q6P3W6 | |
| RELLEVVEPEVLQDS | 771 | Q86T75 | |
| SRELLEVVEPEVLQD | 1041 | Q5TAG4 | |
| EVVEPEVLQDSLDRC | 1046 | Q5TAG4 | |
| RELLEVVEPEVLQDS | 1286 | Q5TAG4 | |
| RELLEVVEPEVLQDS | 431 | Q5TI25 | |
| ELLEVVEPEVLQDSL | 751 | Q5TI25 | |
| ELLEVVEPEVLQDSL | 501 | Q8N660 | |
| ELVEVVEPEVLQDSL | 501 | A0A087WUL8 | |
| LVEVVEPEVLQDSLD | 746 | A0A087WUL8 | |
| VEVVEPEVLQDSLDR | 991 | A0A087WUL8 | |
| SRELVEVVEPEVLQD | 1231 | A0A087WUL8 | |
| EVVEPEVLQDSLDRC | 1236 | A0A087WUL8 | |
| RELVEVVEPEVLQDS | 1476 | A0A087WUL8 | |
| ELLEVVEPEVLQDSL | 1721 | A0A087WUL8 | |
| LEVVEPEVLQDSLDR | 2211 | A0A087WUL8 | |
| SRELLEVVEPEVLQD | 2451 | A0A087WUL8 | |
| EVVEPEVLQDSLDRC | 2456 | A0A087WUL8 | |
| RELLEVVEPEVLQDS | 2696 | A0A087WUL8 | |
| ELLEVVEPEVLQDSL | 2941 | A0A087WUL8 | |
| LEVVEPEVLQDSLDR | 3431 | A0A087WUL8 | |
| SRELLEVVEPEVLQD | 3671 | A0A087WUL8 | |
| EVVEPEVLQDSLDRC | 3676 | A0A087WUL8 | |
| RELLEVVEPEVLQDS | 156 | P0DPF2 | |
| ELLEVVEPEVLQDSL | 401 | P0DPF2 | |
| LEVVEPEVLQDSLDR | 891 | P0DPF2 | |
| SRELLEVVEPEVLQD | 1131 | P0DPF2 | |
| EVVEPEVLQDSLDRC | 1136 | P0DPF2 | |
| RELLEVVEPEVLQDS | 1376 | P0DPF2 | |
| ELLEVVEPEVLQDSL | 1621 | P0DPF2 | |
| LEVVEPEVLQDSLDR | 2111 | P0DPF2 | |
| SRELLEVVEPEVLQD | 2351 | P0DPF2 | |
| EVVEPEVLQDSLDRC | 2356 | P0DPF2 | |
| RELLEVVEPEVLQDS | 2596 | P0DPF2 | |
| ELLEVVEPEVLQDSL | 2841 | P0DPF2 | |
| LEVVEPEVLQDSLDR | 3331 | P0DPF2 | |
| SRELLEVVEPEVLQD | 3571 | P0DPF2 | |
| EVVEPEVLQDSLDRC | 3576 | P0DPF2 | |
| RELLEVVEPEVLQDS | 3816 | P0DPF2 | |
| ELLEVVEPEVLQDSL | 4061 | P0DPF2 | |
| LEVVEPEVLQDSLDR | 4476 | P0DPF2 | |
| SRELLEVVEPEVLQD | 4641 | P0DPF2 | |
| EVVEPEVLQDSLDRC | 4646 | P0DPF2 | |
| SRELLEVVEPEVLQD | 4791 | P0DPF2 | |
| EVVEPEVLQDSLDRC | 4796 | P0DPF2 | |
| RELLEVVEPEVLQDS | 5036 | P0DPF2 | |
| RELLEVVEPEVLQDS | 731 | B4DH59 | |
| LVREVDPNEQLDEDV | 66 | Q16514 | |
| TPEEVVDRIFLLVDE | 141 | Q9UMX6 | |
| EKVEPRDEDLVVAQQ | 851 | O75376 | |
| VDEAVDVGLVNEELR | 1951 | P58107 | |
| EVDNDQLRAIIEADP | 411 | Q53H47 | |
| PESLVDDDVVIVDAV | 671 | Q9Y2G9 | |
| EPDVAERVDLEELIE | 576 | Q8NEM2 | |
| PEEEIVIRDDQDPRE | 441 | Q12769 | |
| ESEVVVERDIILDNP | 581 | Q08188 | |
| VAEEDEVEVILAQEP | 271 | Q9NRA8 | |
| EVEVILAQEPAADQE | 276 | Q9NRA8 | |
| IPDIDVEVDVDELNQ | 201 | Q8N2M8 | |
| TADDEAVLQVPELVV | 386 | Q6J9G0 | |
| EELLAVQVELEPVNA | 116 | A0A494C1R9 | |
| VALVPQEEELDDQKI | 411 | P12956 | |
| ILQDVADEEIAALPR | 66 | O60783 | |
| EELLAVQVELEPVNA | 116 | P0CV99 | |
| LVQVPQEEDRQEEEV | 16 | Q7Z7L9 | |
| PEAEVQALILLDEEV | 326 | Q9C0A1 | |
| AHVLAEEAEIPREVI | 16 | P04085 | |
| PERLEDLEVVQQRFE | 881 | O15020 | |
| DLEVVQQRFETLEPE | 886 | O15020 | |
| EVDRVELAVEAVLQP | 211 | Q9UBI4 | |
| DEDEIVRINPRDILI | 241 | Q7Z699 | |
| LRAEIVTEAEPEVDN | 1611 | P24821 | |
| NEAIEEDIVQSVLRP | 276 | Q7Z5K2 | |
| LEEAEQLEPRVSALE | 171 | Q8NAV1 | |
| EDVEELLVPDVVNEV | 351 | Q9BVJ6 | |
| AVPTIEELEDEEERN | 576 | Q9BVJ6 | |
| EDEIDNSDNLRPVVI | 181 | Q5HYM0 | |
| PESREDVVVVLEDLQ | 116 | Q16670 | |
| SQVVEQDVPEEVDRA | 16 | Q9Y6X8 | |
| DVIEDVVIEDVQCPD | 66 | P17010 | |
| PVVSLVDVLEEDEEL | 16 | Q8N806 | |
| EVEIEVELDREEEPT | 731 | Q96JM2 | |
| DDDVPEGVERVIEQL | 351 | Q9BTW9 | |
| DIEEAIPREIEANDI | 76 | Q5T9L3 | |
| RIEEIPLDQVDIDKE | 971 | Q93009 | |
| EILVTEEPDRDLEAQ | 1236 | P15822 | |
| EDLQRELEIPEQQVD | 106 | Q6P9G9 | |
| RPNNIEAIELAETEE | 176 | Q9UGI0 | |
| PDILQAEEKIEVETR | 926 | Q8TEY7 | |
| DITIDIRPSQEDLEV | 251 | Q03167 | |
| VIAQDENLPEDVVRE | 86 | Q96C45 | |
| IRQEIADIEEGRIDP | 926 | P23378 | |
| QDIDDRIVEANPLLE | 176 | Q9UM54 |